Dallas-based Tenet Healthcare recorded an operating income of $943 million (18.1% operating margin) in the first quarter of 2025, according to its financial report published April 29.
“We had an excellent start to the year driven by strong same-store revenue growth and operational discipline, resulting in earnings and cash flows well ahead of our expectations,” Tenet Chairman and CEO Saum Sutaria, MD, said in the report.
Five things to know:
1. The system posted a net income of $406 million in the three months ended March 31. Tenet recorded a $2.2 billion net income in the first quarter of 2024, which included a pre-tax gain of $2.5 billion ($1.86 billion after tax) associated with the sales of three hospitals in South Carolina and six in California.
2. Tenet recorded net operating revenues of $5.2 billion in the first quarter of 2025, down from $5.4 billion during the same period in 2024. Tenet attributed the decline to its hospital divestitures.
3. Salary, wage and benefit expenses were $2.1 billion in the quarter, down from $2.3 billion during the same quarter last year. Supply expenses were $907 million, down from $928 million.
4. Tenet’s hospital segment reported net operating revenues of $4 billion in the first quarter, down from $4.4 billion during the same period last year. Same-hospital net patient services revenues were $3.5 billion, up from $3.2 billion last year.
5. Its ambulatory segment reported net operating revenues of $1.2 billion in the quarter, up from $995 million last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
